| PACKAGING TYPE: | 9x10 Blister (9 Strips In 1 Box) |
| COMPOSITION: | Empagliflozin 25mg |
| FORMULATION: | Tablet |
| Description: | EMPACON-25 Tablet contains Empagliflozin 25mg, an SGLT2 (sodium-glucose co-transporter 2) inhibitor used for the management of type 2 diabetes mellitus. It works by reducing glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine, thereby lowering blood glucose levels. In addition to glycemic control, it provides cardiovascular protection and supports kidney health, making it a preferred option for long-term diabetes management. |
| Side Effects: | Common side effects may include: Increased urination Urinary tract infections Genital fungal infections Thirst Dehydration Serious side effects: Ketoacidosis (rare but serious) Severe dehydration Kidney impairment Low blood pressure Allergic reactions |
| How to Use: | Take EMPACON-25 Tablet as prescribed by a healthcare professional Usually taken once daily, preferably in the morning Swallow the tablet whole with water Can be taken with or without food Maintain adequate hydration |
| Precaution: | Monitor kidney function regularly Stay hydrated to prevent dehydration Use cautiously in elderly patients Inform your doctor about other antidiabetic medications Not recommended for type 1 diabetes Avoid use during pregnancy or breastfeeding without medical advice |
| Product Benefits: | Strong and effective blood sugar control Supports weight loss in diabetic patients Reduces risk of cardiovascular complications Provides renal protection Low risk of hypoglycemia when used alone Once-daily dosing improves patient compliance |
Frequently Asked Questions
It is used to manage blood sugar levels in patients with type 2 diabetes.
Yes, it contains a higher dose and provides stronger glucose-lowering effect.
Yes, it may aid in modest weight reduction in diabetic patients.













